STTK Shattuck Labs, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 11, 2026
$6.73
· of 52w range
· above low
· to high
$1.7052w low
$8.3352w high
Market Cap (MRQ)
$678M
P/E (TTM)
-15.3
EPS (TTM)
$-0.44
Revenue (TTM)
$1M
your badges
52W Range
$2–$8
Analyst Rating
BUY
Price Target
$15
P/E
-15.3
ROE
-39.2%
Net Profit Margin
-5256.8%
Your badge strip is empty — pin a metric anywhere on this page.
STTK Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.73
Market Cap (MRQ)
$678M
P/E (TTM)
-15.3
EPS (TTM)
$-0.44
Revenue (TTM)
$1M
ROE (TTM)
-39.2%
52W Range
$2–$8
STTK Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$1M2019-12-31 → 2025-12-31
EPS$-0.702020-12-31 → 2025-12-31
Free Cash Flow$-40M2020-12-31 → 2025-12-31
Net margin-5256.8%2020-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | STTK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | -15.35Y avg ≈-3.7 | ≈-3.7 | · | · | |
| P/S (TTM) | 677.95Y avg ≈149.0 | ≈149.0 | 54.5 | Overvalued | |
| P/B (MRQ) | 3.25Y avg ≈1.8 | ≈1.8 | 2.9 | Overvalued | |
| Price / FCF | -10.75Y avg ≈-4.1 | ≈-4.1 | · | · | |
| Price / Cash Flow | -10.75Y avg ≈-4.3 | ≈-4.3 | · | · | |
| Price / Tangible Book | 5.25Y avg ≈1.5 | ≈1.5 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | STTK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | -5578.7%5Y avg ≈-6674.8% | ≈-6674.8% | -1056.2% | Weak | |
| EBITDA Margin | -4780.8%5Y avg ≈-6401.9% | ≈-6401.9% | -1056.2% | Weak | |
| Net Profit Margin (TTM) | -5256.8%5Y avg ≈-6483.7% | ≈-6483.7% | -1000.6% | Weak | |
| ROA (TTM) | -36.9%5Y avg ≈-39.0% | ≈-39.0% | -33.0% | Weak | |
| ROE (TTM) | -39.2%5Y avg ≈-52.3% | ≈-52.3% | -39.4% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | STTK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 27.65Y avg ≈10.8 | ≈10.8 | 8.9 | Strong liquidity | |
| Quick Ratio | 7.75Y avg ≈6.1 | ≈6.1 | 5.8 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | STTK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -82.5%5Y avg ≈84.2% | ≈84.2% | · | · | |
| Revenue CAGR 3Y | 15.3%5Y avg ≈-24.0% | ≈-24.0% | · | · | |
| Revenue CAGR 5Y | -36.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | STTK | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.05Y avg ≈0.0 | ≈0.0 | 0.4 | Weak | |
| Revenue / Employee | ≈$25.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
6.5%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 12, 2026 | $-0.12 | $-0.12 | -0.25% |
| March 31, 2026 | May 13, 2026 | $-0.13 | $-0.14 | 7.7% |
| Dec. 31, 2025 | $-0.12 | $-0.14 | 13.9% | |
| Sept. 30, 2025 | $-0.14 | $-0.15 | 7.7% | |
| June 30, 2025 | $-0.24 | $-0.25 | 4.0% | |
| March 31, 2025 | $-0.27 | $-0.29 | 5.9% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1M | $6M | $2M | $652.0K | $30M | $10M | $10M | |
| R&D Expense | $35M | $67M | $74M | $83M | $57M | $37M | $29M | |
| SG&A Expense | $17M | $19M | $19M | $21M | $19M | $9M | $6M | |
| Operating Expenses | $53M | $86M | $94M | $104M | $75M | $47M | $35M | |
| Operating Income | $-52M | $-81M | $-92M | $-103M | $-45M | $-37M | $-25M | |
| Interest Income | $3M | $5M | $5M | $2M | $625.0K | $549.0K | $1M | |
| Other Non-op | $-4.0K | $-17.0K | $-10.0K | $-208.0K | $-330.0K | $-221.0K | $-99.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | $-24M | |
| EPS (Basic) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| EPS (Diluted) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · | |
| Shares (Basic) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| Shares (Diluted) | 69,584,937 | 50,758,290 | 42,600,190 | 42,378,895 | 42,032,384 | 15,506,067 | · | |
| EBITDA | $-48M | · | $-88M | $-100M | $-44M | $-36M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $57M | $126M | $47M | $92M | $158M | $7M | |
| Prepaid Expense | $4M | $6M | $13M | $23M | $19M | $10M | $3M | |
| Current Assets | $82M | $79M | $143M | $185M | $288M | $346M | $42M | |
| PP&E (Net) | $6M | $10M | $14M | $18M | $10M | $3M | $2M | |
| PP&E (Gross) | $23M | $23M | $23M | $23M | $13M | $4M | $3M | |
| Accum. Depreciation | $17M | $13M | $10M | $6M | $3M | $1M | $862.0K | |
| Other Non-current Assets | $1M | $2M | $3M | $3M | $381.0K | $349.0K | $90.0K | |
| Total Assets | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Accounts Payable | $2M | $2M | $2M | $7M | $10M | $2M | $3M | |
| Current Liabilities | $7M | $9M | $11M | $25M | $25M | $17M | $20M | |
| Capital Leases | $2M | $3M | $3M | $4M | $0 | · | · | |
| Total Liabilities | $9M | $11M | $15M | $29M | $27M | $39M | $30M | |
| Common Stock | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $1.0K | |
| Paid-in Capital | $513M | $461M | $451M | $396M | $389M | $382M | $887.0K | |
| Retained Earnings | $-431M | $-382M | $-306M | $-219M | $-117M | $-72M | $-35M | |
| AOCI | $6.0K | $2.0K | $4.0K | $-877.0K | $-560.0K | $-63.0K | $54.0K | |
| Stockholders' Equity | $82M | $80M | $145M | $176M | $272M | $310M | $-35M | |
| Liabilities + Equity | $91M | $91M | $160M | $205M | $299M | $349M | $45M | |
| Shares Outstanding | 63,279,843 | 47,714,708 | 47,260,108 | 42,390,586 | 42,338,898 | 41,767,431 | 7,600,877 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $1M | $600.0K | $500.0K | |
| Stock-based Comp | $7M | $10M | $7M | $6M | $5M | $1M | $461.0K | |
| Other Non-cash | $-2M | · | $-5M | $-2M | $-19M | $1M | · | |
| Operating Cash Flow | $-40M | $-61M | $-81M | $-94M | $-57M | $-34M | $-21M | |
| CapEx | $71.0K | $59.0K | $407.0K | $12M | $8M | $727.0K | $470.0K | |
| Investing Cash Flow | $-8M | $-9M | $111M | $49M | $-10M | $-146M | $-4M | |
| Stock Issued | $44M | · | $48M | $0 | · | · | · | |
| Net Stock Activity | $44M | · | $48M | · | · | · | · | |
| Financing Cash Flow | $45M | $787.0K | $49M | $171.0K | $2M | $331M | $-64.0K | |
| Net Change in Cash | $-3M | $-68M | $78M | $-45M | $-66M | $151M | $-25M | |
| Free Cash Flow | $-40M | · | $-82M | $-106M | $-65M | $-34M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -5150.8% | · | -5549.6% | -15848.0% | -150.8% | -371.8% | · | |
| Net Margin | -4880.9% | · | -5268.4% | -15635.7% | -149.8% | -368.5% | · | |
| EBITDA Margin | -4780.8% | · | -5308.2% | -15372.6% | -146.2% | -365.7% | · | |
| ROA | -53.6% | · | -47.9% | -40.5% | -13.9% | -18.6% | · | |
| ROE | -70.0% | · | -67.8% | -54.3% | -16.9% | -29.1% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.7 | · | 12.5 | 7.4 | 11.7 | 20.5 | · | |
| Quick Ratio | 7.7 | · | 11.0 | 1.9 | 3.8 | 9.4 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.1 | 0.1 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.30 | · | $3.06 | $4.16 | $6.42 | $7.42 | · | |
| Revenue / Share | $0.01 | · | $0.04 | $0.02 | $0.71 | · | · | |
| Cash Flow / Share | $-0.57 | · | $-1.91 | $-2.23 | $-1.36 | · | · | |
| Cash / Share | $0.86 | · | $2.66 | $1.12 | $2.18 | $3.78 | · | |
| EPS (TTM) | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 | $-2.36 | · |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -82.5% | 245.3% | 154.1% | -97.8% | 202.2% | · | · | |
| Revenue CAGR 3Y | 15.3% | -42.4% | -45.0% | · | · | · | · | |
| Revenue CAGR 5Y | -36.8% | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $6M | $2M | $652.0K | $30M | $10M | · | |
| Net Income TTM | $-49M | $-75M | $-87M | $-102M | $-45M | $-37M | · | |
| Market Cap | $231M | · | $337M | $97M | $360M | $2.19B | · | |
| P/E | -5.2 | -0.8 | -3.5 | -1.0 | -8.0 | -22.2 | · | |
| P/S | 231.0 | · | 203.4 | 149.5 | 12.0 | 220.4 | · | |
| P/B | 2.8 | · | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Tangible Book | 2.8 | 0.7 | 2.3 | 0.6 | 1.3 | 7.1 | · | |
| P / Cash Flow | -5.8 | · | -4.1 | -1.0 | -6.3 | -65.0 | · | |
| P / FCF | -5.8 | · | -4.1 | -0.9 | -5.5 | -63.7 | · | |
| Earnings Yield | -19.2% | -123.1% | -28.7% | -104.8% | -12.6% | -4.5% | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $3M | $2M | $1M | $714.0K | $686.0K | $200.0K | $57.0K | $390.0K | $212.0K | |
| R&D Expense | $12M | $11M | $9M | $8M | $9M | $10M | $15M | $16M | $19M | $16M | $15M | $24M | $18M | $17M | $22M | $19M | |
| SG&A Expense | $4M | $5M | $4M | $4M | $4M | $4M | $4M | $5M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $7M | |
| Operating Expenses | $16M | $16M | $13M | $12M | $13M | $14M | $20M | $21M | $25M | $21M | $20M | $29M | $23M | $22M | $27M | $25M | |
| Operating Income | $-16M | $-16M | $-13M | $-11M | $-13M | $-14M | $-20M | $-18M | $-23M | $-20M | $-19M | $-29M | $-23M | $-22M | $-26M | $-25M | |
| Interest Income | $1M | $779.0K | · | · | $804.0K | $689.0K | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-26.0K | $-1.0K | $-2M | $660.0K | $-230.0K | $-2.0K | $-4M | $1M | $1M | $2M | $-3M | $1M | $1M | $937.0K | $-727.0K | $594.0K | |
| Net Income | $-15M | $-15M | $-13M | $-10M | $-12M | $-14M | $-19M | $-17M | $-22M | $-19M | $-18M | $-28M | $-21M | $-21M | $-25M | $-25M | |
| EPS (Basic) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| EPS (Diluted) | $-0.12 | $-0.13 | $-0.05 | $-0.14 | $-0.24 | $-0.27 | $-0.37 | $-0.33 | $-0.42 | $-0.37 | $-0.41 | $-0.65 | $-0.50 | $-0.49 | $-0.60 | $-0.58 | |
| Shares (Basic) | 129,779,297 | 112,234,551 | · | 72,184,818 | 51,002,247 | 50,965,815 | · | 50,833,538 | 50,791,241 | 50,566,394 | · | 42,477,642 | 42,467,664 | 42,439,204 | · | 42,386,470 | |
| Shares (Diluted) | 129,779,297 | 112,234,551 | · | 72,184,818 | 51,002,247 | 50,965,815 | · | 50,833,538 | 50,791,241 | 50,566,394 | · | 42,477,642 | 42,467,664 | 42,439,204 | · | 42,386,470 | |
| EBITDA | $-16M | $-16M | · | $-11M | $-13M | $-14M | · | $-18M | $-23M | $-20M | · | $-29M | $-23M | $-22M | · | $-25M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $63M | $90M | $54M | $43M | $50M | $61M | $57M | $44M | $61M | $76M | $126M | $41M | $72M | $66M | $47M | $40M | |
| Prepaid Expense | $5M | $3M | $4M | $5M | $4M | $6M | $6M | $9M | $9M | $16M | $13M | $12M | $19M | $22M | $23M | $16M | |
| Current Assets | $213M | $94M | $82M | $91M | $55M | $66M | $79M | $99M | $114M | $131M | $143M | $113M | $136M | $158M | $185M | $202M | |
| PP&E (Net) | $5M | $5M | $6M | $7M | $8M | $9M | $10M | $11M | $12M | $13M | $14M | $15M | $16M | $17M | $18M | $18M | |
| PP&E (Gross) | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | · | · | $23M | · | |
| Accum. Depreciation | · | · | $17M | · | · | · | $13M | · | · | · | $10M | · | · | · | $6M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Assets | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Accounts Payable | $4M | $1M | $2M | $1M | $475.0K | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $5M | $7M | $3M | |
| Current Liabilities | $8M | $4M | $7M | $5M | $5M | $7M | $9M | $12M | $15M | $14M | $11M | $14M | $13M | $16M | $25M | $19M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Total Liabilities | $10M | $6M | $9M | $7M | $7M | $10M | $11M | $15M | $18M | $18M | $15M | $18M | $17M | $20M | $29M | $24M | |
| Common Stock | $10.0K | $7.0K | $7.0K | $7.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | |
| Paid-in Capital | $672M | $541M | $513M | $511M | $465M | $463M | $461M | $460M | $457M | $454M | $451M | $401M | $400M | $398M | $396M | $394M | |
| Retained Earnings | $-460M | $-445M | $-431M | $-418M | $-408M | $-395M | $-382M | $-363M | $-346M | $-325M | $-306M | $-289M | $-261M | $-240M | $-219M | $-194M | |
| AOCI | $-63.0K | $0 | $6.0K | $3.0K | $1.0K | $0 | $2.0K | $52.0K | $-5.0K | $-14.0K | $4.0K | $7.0K | $-74.0K | $-339.0K | $-877.0K | $-1M | |
| Stockholders' Equity | $211M | $96M | $82M | $93M | $57M | $68M | $80M | $97M | $111M | $129M | $145M | $113M | $138M | $158M | $176M | $199M | |
| Liabilities + Equity | $221M | $102M | $91M | $100M | $64M | $77M | $91M | $112M | $129M | $146M | $160M | $130M | $155M | $178M | $205M | $223M | |
| Shares Outstanding | 100,726,022 | 75,581,787 | 63,279,843 | 63,151,789 | 47,903,215 | 47,899,240 | 47,714,708 | 47,739,708 | 47,727,269 | 47,519,219 | 47,260,108 | 42,485,485 | 42,471,335 | 42,460,258 | 42,390,586 | 42,390,586 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-10M | $-13M | $-8M | $-9M | $-10M | $-12M | $-17M | $-16M | $-11M | $-16M | $-19M | $-17M | $-19M | $-26M | $-24M | $-28M | |
| CapEx | · | · | $0 | $71.0K | · | · | $0 | $42.0K | $17.0K | $0 | $17.0K | $19.0K | $296.0K | $75.0K | $693.0K | $750.0K | |
| Investing Cash Flow | $-145M | $24M | $20M | $-43M | $0 | $16M | $31M | $-821.0K | $-5M | $-33M | $56M | $-15M | $24M | $45M | $31M | $30M | |
| Stock Issued | $80M | $21M | $-5.0K | $44M | $0 | $0 | · | $0 | · | · | · | $0 | · | · | · | · | |
| Net Stock Activity | · | $21M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $128M | $26M | $134.0K | $44M | $0 | $-57.0K | $-72.0K | $23.0K | $1M | $-184.0K | $49M | $21.0K | $33.0K | $0 | $0 | $27.0K | |
| Net Change in Cash | $-27M | $36M | $12M | $-8M | $-10M | $4M | $14M | $-17M | $-15M | $-50M | $85M | $-31M | $6M | $19M | $8M | $2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-16M | · | · | · | $-27M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| Net Margin | · | · | · | -1005.6% | · | · | · | -556.4% | -1339.5% | -1659.6% | · | -4014.7% | -10673.0% | -36357.9% | · | -11620.3% | |
| EBITDA Margin | · | · | · | -1071.6% | · | · | · | -597.9% | -1427.1% | -1797.7% | · | -4168.8% | -11373.5% | -38001.8% | · | -11900.5% | |
| ROA | -10.6% | -16.5% | · | -9.5% | -12.9% | -12.3% | · | -13.8% | -15.2% | -11.4% | · | -15.6% | -10.5% | -9.2% | · | -9.2% | |
| ROE | -11.3% | -18.1% | · | -10.6% | -14.9% | -14.0% | · | -15.9% | -17.3% | -12.9% | · | -17.6% | -11.8% | -10.2% | · | -10.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 27.6 | 22.1 | · | 17.0 | 10.2 | 9.1 | · | 8.0 | 7.6 | 9.1 | · | 8.0 | 10.5 | 9.9 | · | 10.5 | |
| Quick Ratio | 8.2 | 21.3 | · | 8.0 | 9.5 | 8.3 | · | 3.5 | 4.0 | 5.3 | · | 2.9 | 5.5 | 4.1 | · | 2.1 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.10 | $1.27 | · | $1.48 | $1.19 | $1.41 | · | $2.02 | $2.32 | $2.71 | · | $2.65 | $3.26 | $3.71 | · | $4.70 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.01 | $0.00 | $0.00 | · | $0.06 | $0.03 | $0.02 | · | $0.02 | $0.00 | $0.00 | · | $0.01 | |
| Cash Flow / Share | · | $-0.12 | · | · | · | $-0.24 | · | · | · | $-0.32 | · | · | · | $-0.62 | · | · | |
| Cash / Share | $0.63 | $1.20 | · | $0.67 | $1.05 | $1.27 | · | $0.92 | $1.27 | $1.60 | · | $0.96 | $1.69 | $1.56 | · | $0.94 | |
| EPS (TTM) | $-0.44 | $-0.56 | · | $-1.02 | $-1.21 | $-1.39 | · | $-1.53 | $-1.85 | $-1.93 | · | $-2.24 | $-2.17 | $-2.32 | · | $-1.63 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $1M | $1M | · | $1M | $3M | $5M | · | $6M | $4M | $3M | · | $1M | $859.0K | $709.0K | · | $30M | |
| Net Income TTM | $-53M | $-50M | · | $-55M | $-62M | $-71M | · | $-74M | $-85M | $-85M | · | $-95M | $-92M | $-98M | · | $-69M | |
| Market Cap | $699M | $486M | · | $151M | $38M | $46M | · | $167M | $184M | $425M | · | $65M | $133M | $125M | · | $114M | |
| P/E | -15.8 | -11.5 | · | -2.3 | -0.7 | -0.7 | · | -2.3 | -2.1 | -4.6 | · | -0.7 | -1.4 | -1.3 | · | -1.7 | |
| P/S | 699.0 | 486.0 | · | 150.9 | 12.7 | 9.9 | · | 25.9 | 44.7 | 156.5 | · | 48.4 | 154.3 | 176.1 | · | 3.8 | |
| P/B | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Tangible Book | 3.3 | 5.1 | · | 1.6 | 0.7 | 0.7 | · | 1.7 | 1.7 | 3.3 | · | 0.6 | 1.0 | 0.8 | · | 0.6 | |
| P / Cash Flow | · | -36.2 | · | · | · | -3.8 | · | · | · | -26.3 | · | · | · | -4.7 | · | · | |
| Earnings Yield | -6.3% | -8.7% | · | -42.7% | -152.8% | -146.3% | · | -43.8% | -47.9% | -21.6% | · | -147.4% | -69.5% | -78.9% | · | -60.4% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $1M | $6M | $2M | $652.0K | $30M |
| Operating Margin % | -5150.8% | · | -5549.6% | -15848.0% | -150.8% |
| Net Income | $-49M | $-75M | $-87M | $-102M | $-45M |
| Diluted EPS | $-0.70 | $-1.49 | $-2.05 | $-2.41 | $-1.07 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 11.7 | · | 12.5 | 7.4 | 11.7 |
| Quick Ratio | 7.7 | · | 11.0 | 1.9 | 3.8 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-40M | · | $-82M | $-106M | $-65M |
Institutional owners (13F) 113 filers · $483.8M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
113
Value held
$483.8M
New positions
45
Exited positions
18
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 45 (+20 vs prior Q) | 18 (+14 vs prior Q) | 35 (+4 vs prior Q) | 14 (0 vs prior Q) | +29.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $56,367,922 | 8,122,179 | 11.65% | Shares |
| Redmile Group, LLC | $47,830,709 | 6,892,033 | 9.89% | Shares |
| ORBIMED ADVISORS LLC | $43,764,521 | 6,306,127 | 9.05% | Shares |
| Prosight Management, LP | $41,347,666 | 5,957,877 | 8.55% | Shares |
| BlackRock, Inc. | $27,314,521 | 3,935,810 | 5.65% | Shares |
| Frazier Life Sciences Management, L.P. | $26,025,000 | 3,750,000 | 5.38% | Shares |
| NEXTBio Capital Management LP | $25,867,795 | 3,727,348 | 5.35% | Shares |
| Deep Track Capital, LP | $25,724,734 | 3,706,734 | 5.32% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $22,262,583 | 3,207,865 | 4.60% | Shares |
| PINNACLE ASSOCIATES LTD | $12,987,807 | 1,871,442 | 2.68% | Shares |
| WELLINGTON MANAGEMENT GROUP LLP | $12,269,490 | 1,767,938 | 2.54% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $11,000,534 | 1,584,756 | 2.27% | Shares |
| CLARK ESTATES INC/NY | $9,925,359 | 1,430,167 | 2.05% | Shares |
| Aberdeen Group plc | $9,756,606 | 1,405,851 | 2.02% | Shares |
| VANGUARD GROUP INC | $8,678,773 | 2,377,746 | 1.79% | Shares |
| Point72 Asset Management, L.P. | $8,124,880 | 1,170,732 | 1.68% | Shares |
| 683 Capital Management, LLC | $8,031,079 | 1,157,216 | 1.66% | Shares |
| STATE STREET CORP | $7,123,174 | 1,026,394 | 1.47% | Shares |
| Boxer Capital Management, LLC | $6,940,000 | 1,000,000 | 1.43% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6,572,076 | 946,985 | 1.36% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $5,161,701 | 743,761 | 1.07% | Shares |
| GOLDMAN SACHS GROUP INC | $4,117,668 | 593,324 | 0.85% | Shares |
| TD Asset Management Inc | $3,878,599 | 558,876 | 0.80% | Shares |
| NORTHERN TRUST CORP | $3,610,993 | 520,316 | 0.75% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $3,216,100 | 463,415 | 0.66% | Shares |
| S&G Foundation | $3,024,098 | 435,749 | 0.63% | Shares |
| ALGERT GLOBAL LLC | $2,923,038 | 421,187 | 0.60% | Shares |
| FMR LLC | $2,724,616 | 392,596 | 0.56% | Shares |
| DEUTSCHE BANK AG\ | $2,474,305 | 356,528 | 0.51% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $2,131,968 | 307,200 | 0.44% | Call option |
| Connor, Clark & Lunn Investment Management Ltd. | $1,988,234 | 286,489 | 0.41% | Shares |
| Hillsdale Investment Management Inc. | $1,828,121 | 263,418 | 0.38% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1,575,873 | 227,071 | 0.33% | Shares |
| Bank of New York Mellon Corp | $1,516,424 | 218,505 | 0.31% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1,395,634 | 201,100 | 0.29% | Put option |
| Caption Management, LLC | $1,388,000 | 200,000 | 0.29% | Call option |
| MILLENNIUM MANAGEMENT LLC | $1,346,416 | 194,008 | 0.28% | Shares |
| West Tower Group, LLC | $1,329,878 | 191,625 | 0.27% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1,317,899 | 189,899 | 0.27% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,290,472 | 185,947 | 0.27% | Shares |
| MORGAN STANLEY | $1,261,081 | 181,712 | 0.26% | Shares |
| TAKEDA PHARMACEUTICAL CO LTD | $1,232,329 | 515,619 | 0.25% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $1,080,156 | 155,642 | 0.22% | Shares |
| XTX Topco Ltd | $650,653 | 93,754 | 0.13% | Shares |
| TWO SIGMA ADVISERS, LP | $622,690 | 170,600 | 0.13% | Shares |
| Jump Financial, LLC | $616,272 | 88,800 | 0.13% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $600,039 | 86,461 | 0.12% | Shares |
| Nuveen, LLC | $565,069 | 81,422 | 0.12% | Shares |
| LBJ Family Wealth Advisors, Ltd. | $560,000 | 82,177 | 0.12% | Shares |
| Pathstone Holdings, LLC | $513,255 | 73,956 | 0.11% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Redmile Group, LLC, Jeremy C. Green, Redmile Biopharma Investments II, L.P. ×7 filings | July 17, 2026 | 9.90% | Amendment | · | SEC |
| ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC, OrbiMed Genesis GP LLC ×2 filings | June 15, 2026 | 9.99% | Amendment | · | SEC |
| JOSIAH HORNBLOWER ×2 filings | Dec. 9, 2022 | · | Initial filing | Passive investment | SEC |
| Taylor Schreiber, M.D., Ph.D. | Oct. 23, 2020 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 18 insiders · 7 officers · 12 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Taylor Schreiber | Chief Executive Officer | May 12, 2026 M | 122,222 | 0 | 0 | $0 |
| Andrew R Neill | Chief Financial Officer | May 12, 2026 M | 292,251 | 0 | 0 | $0 |
| Abhinav A. Shukla | Chief Technical Officer | July 6, 2026 M | 98,533 | 0 | 4 | $-183,249 |
| Arundathy N. Pandite | Chief Medical Officer | June 30, 2026 S | 136,219 | 0 | 2 | $-408,600 |
| Stephen Stout | General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer | May 15, 2026 M | 93,366 | 0 | 0 | $0 |
| Casi Deyoung | Chief Business Officer | Jan. 25, 2026 F | 73,480 | 0 | 0 | $0 |
| Erin Ator Thomson | General Counsel | Jan. 25, 2023 A | 103,209 | 0 | 0 | $0 |
| Mona Ashiya | Director | June 11, 2026 P | 1,051,021 | 0 | 0 | $0 |
| Clay B Siegall | Director | June 9, 2026 P | 318,608 | 1 | 0 | $250,000 |
| Daniel G. Baker | Director | May 29, 2026 A | · | 0 | 0 | $0 |
| Helen M Boudreau | Director | May 29, 2026 A | · | 0 | 0 | $0 |
| George Golumbeski | Director | May 29, 2026 A | 54,613 | 0 | 0 | $0 |
| Neil W Gibson | Director | May 29, 2026 A | · | 0 | 0 | $0 |
| Amy Kate Sasser | Director | July 14, 2025 A | · | 0 | 0 | $0 |
| Carrie Brownstein | Director | July 14, 2025 A | · | 0 | 0 | $0 |
| Tyler Brous | Director | July 14, 2025 A | 238,088 | 0 | 0 | $0 |
| Michael Stewart Lee | Director | July 14, 2025 A | · | 0 | 0 | $0 |
| Josiah Hornblower | Director | July 15, 2021 S | 2,966,709 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 15 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.09% | 208,976 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 501,709 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 57,611 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 29,182 NS | July 31, 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 51,205 SH | Oct. 1, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 1,581,833 SH | Sept. 11, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.01% | 767,988 SH | Aug. 19, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 353,062 SH | Aug. 19, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.01% | 153,549 SH | Aug. 19, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 49,623 NS | July 31, 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,366,616 SH | Aug. 19, 2026 | Daily |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.00% | 6,884 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 5,109 SH | Aug. 19, 2026 | Daily |
| DFAC · Dimensional ETF Trust | 0.00% | 2,719 NS | July 31, 2026 | N-PORT |
| IWN · iShares Trust | · | 96,671 SH | Sept. 11, 2026 | Daily |
STTK Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 17 analysts
BUY
Median target
$15.00
+122.9%
6 35.3%
Strong Buy
10 58.8%
Buy
1 5.9%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
9 analysts · 2026-10-02Mean target $15.00 +122.9%
← Below all targets
Current price $6.73
Low$10.00
Mean$15.00
High$18.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| STTK | $231M | -5.2 | -82.5% | -4880.9% | -70.0% | · |
| NVCT | $194M | -5.7 | · | · | -149.9% | · |
| IMMX | $277M | -5.9 | · | · | -59.8% | · |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
| AURA | $347M | -3.1 | -29.7% | -1601.4% | -68.2% | · |
| CLYM | $191M | -4.5 | · | · | -34.6% | · |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | · |
| SGMT | · | -3.7 | · | · | -42.3% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 11, 2026